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Draft Whole-Genome Sequence of Bacillus sonorensis Strain L12, a
Source of Nonribosomal Lipopeptides
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The Bacillus sonorensis L12 draft genome sequence is approximately 4,647,754 bp in size with a GC content of 45.2%. Over
86% of the genome contains protein-encoding genes, including several gene clusters for de novo biosynthesis of the nonribo-
somal lipopeptides iturin, bacitracin, and fengycin, which could mean that the strain exhibits antifungal effects.
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Bacillus sonorensis is a Gram-positive aerobic-endospore-forming bacterium and amember of theBacillus subtilis group
of microorganisms. It was first isolated from the Sonoran Desert
soil and is phenotypically and genotypically closely related to Ba-
cillus licheniformis by sharing traits such as being facultatively an-
aerobic (1–3). However, the B. sonorensis and B. licheniformis spe-
cies can be phenotypically distinguished based on colony
pigmentation (1, 4) and sensitivity to different level of clindamy-
cin (5). The B. licheniformis sp. is exploited industrially for large-
scale production of many enzymes, antibiotics, and biochemicals
(3) and works as a host for cloning of several genes encoding
-amylases, etc. Several members of the B. subtilis group are also
used as probiotics and biocontrol agents in crop farming (6, 7).
Thus, given that the industrially relevant organismB. licheniformis
is closely related to B. sonorensis, about which little is known, we
sequenced the genome of B. sonorensis L12, which was isolated
from Gergoush primary starter materials in Sudan (4). It is ex-
pected that the information obtained can be used to explore the
biotechnological relevance of this organism as well as its genomics
and phylogenetic status related tomembers of theB. subtilis group
of microorganisms and thereby enhance our limited knowledge
on the B. sonorensis species.
The genomic DNA of strain L12 was isolated from overnight
culture using a commercial DNA isolation kit (GenElute bacterial
genomic DNA kit, NA2110; Sigma-Aldrich Co., St. Louis, MO).
Sequencing was performed at the Beijing Genomics Institute
(BGI, Shenzhen, China) using a combination of randomly
sheared libraries with inserts of 0.5 to 2 kb in size. The genomic
DNA was sequenced using the Illumina Hiseq platform with a
total coverage of 70. The reads were assembled into contigs us-
ingCLCGenomicsWorkbench v. 5 (CLCBio, Aarhus, Denmark),
which was also used to determine the nucleotide sequence statis-
tics. Genome annotation and preparation for submission to
GenBank were performed using the NCBI Prokaryotic Genomes
Automatic Annotation Pipeline (PGAAP). Putative tRNAs were
predicted using the tRNAscan-SE 1.21 Server (8) programs.
The assembled draft genome sequence of strain L12 contains
34 contigs, a genome size of 4,647,754 bp, and a GC content of
45.2%. The genomewas 425,108 bp larger than theB. licheniformis
DSM13T genome. Strain L12 has 78 tRNA genes and 4,236
protein-coding genes representing 86.8% of the draft genome se-
quence.
Preliminary genome analysis revealed that strain L12 carries
gene clusters for de novo biosyntheses of the nonribosomal lipo-
peptides fengycin, iturin, and bacitracin, which have potential
biotechnological applications (9, 10). It therefore represents a po-
tential strain which can be used as a cloning tool for genetic engi-
neering and production of improved and novel antimicrobial
agents and also as a bioprotective agent for controlling plant fun-
gal pathogens in crop farming. Further comparative genomic
analyses will also provide valuable insight into the evolutionary
and phylogenetic status of this species and contribute to a deeper
understanding of its ecology and evolution.
Nucleotide sequence accession numbers. This whole genome
shotgun project has been deposited at DDBJ/EMBL/GenBank un-
der the accession number AOFM00000000. The version described
in this paper is the first version, AOFM01000000.
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